Search

Here, we consider the elasto-capillary fluid-structure interaction problem studied in Bhopalam, Bueno & Gomez (2022), i.e., three immiscible fluids in contact with an elastic solid. In this article, we show that the solution of this fluid-structure interaction problem satisfies an energy dissipation law., Comment: updated author information and acknowledgements section

Collective migration of eukaryotic cells is often guided by chemotaxis, and is critical in several biological processes, such as cancer metastasis, wound healing, and embryogenesis. Understanding collective chemotaxis has challenged experimental, theoretical and computational scientists because cells can sense very small chemoattractant gradients that are tightly controlled by cell-cell interactions and the regulation of the chemoattractant distribution by the cells. Computational models of collective cell migration that offer a high-fidelity resolution of the cell motion and chemoattractant dynamics in the extracellular space have been limited to a small number of cells. Here, we present Dynamic cluster field modeling (DCF), a novel computational method that enables simulations of collective chemotaxis of cellular systems with O(1000) cells and high-resolution transport dynamics of the chemoattractant in the time-evolving extracellular space. We illustrate the efficiency and predictive capabilities of our approach by comparing our numerical simulations with experiments in multiple scenarios that involve chemoattractant secretion and uptake by the migrating cells, regulation of the attractant distribution by cell motion, and interactions of the chemoattractant with an enzyme. The proposed algorithm opens new opportunities to address outstanding problems that involve collective cell migration in the central nervous system, immune response and cancer metastasis.

Most passive droplet transport strategies rely on spatial variations of material properties to drive droplet motion, leading to gradient-based mechanisms with intrinsic length scales that limit the droplet velocity or the transport distance. Here, we propose droplet {\it fibrotaxis}, a novel mechanism that leverages an anisotropic fiber-reinforced deformable solid to achieve spontaneous and gradient-free droplet transport. Using high-fidelity simulations, we identify the fluid wettability, fiber orientation, anisotropy strength and elastocapillary number as critical parameters that enable controllable droplet velocity and long-range droplet transport. Our results highlight the potential of fibrotaxis as a droplet transport mechanism that can have a strong impact on self-cleaning surfaces, water harvesting and medical diagnostics., Comment: revised paper

Active surveillance (AS) is a suitable management option for newly-diagnosed prostate cancer (PCa), which usually presents low to intermediate clinical risk. Patients enrolled in AS have their tumor closely monitored via longitudinal multiparametric magnetic resonance imaging (mpMRI), serum prostate-specific antigen tests, and biopsies. Hence, the patient is prescribed treatment when these tests identify progression to higher-risk PCa. However, current AS protocols rely on detecting tumor progression through direct observation according to standardized monitoring strategies. This approach limits the design of patient-specific AS plans and may lead to the late detection and treatment of tumor progression. Here, we propose to address these issues by leveraging personalized computational predictions of PCa growth. Our forecasts are obtained with a spatiotemporal biomechanistic model informed by patient-specific longitudinal mpMRI data. Our results show that our predictive technology can represent and forecast the global tumor burden for individual patients, achieving concordance correlation coefficients ranging from 0.93 to 0.99 across our cohort (n=7). Additionally, we identify a model-based biomarker of higher-risk PCa: the mean proliferation activity of the tumor (p=0.041). Using logistic regression, we construct a PCa risk classifier based on this biomarker that achieves an area under the receiver operating characteristic curve of 0.83. We further show that coupling our tumor forecasts with this PCa risk classifier enables the early identification of PCa progression to higher-risk disease by more than one year. Thus, we posit that our predictive technology constitutes a promising clinical decision-making tool to design personalized AS plans for PCa patients.

Despite the remarkable advances in cancer diagnosis, treatment, and management that have occurred over the past decade, malignant tumors remain a major public health problem. Further progress in combating cancer may be enabled by personalizing the delivery of therapies according to the predicted response for each individual patient. The design of personalized therapies requires patient-specific information integrated into an appropriate mathematical model of tumor response. A fundamental barrier to realizing this paradigm is the current lack of a rigorous, yet practical, mathematical theory of tumor initiation, development, invasion, and response to therapy. In this review, we begin by providing an overview of different approaches to modeling tumor growth and treatment, including mechanistic as well as data-driven models based on ``big data" and artificial intelligence. Next, we present illustrative examples of mathematical models manifesting their utility and discussing the limitations of stand-alone mechanistic and data-driven models. We further discuss the potential of mechanistic models for not only predicting, but also optimizing response to therapy on a patient-specific basis. We then discuss current efforts and future possibilities to integrate mechanistic and data-driven models. We conclude by proposing five fundamental challenges that must be addressed to fully realize personalized care for cancer patients driven by computational models.

We present the method of Direct van der Waals simulation (DVS) to study computationally flows with liquid-vapor phase transformations. Our approach is based on a novel discretization of the Navier-Stokes-Korteweg equations, that couple flow dynamics with van der Waals' non-equilibrium thermodynamic theory of phase transformations, and opens an opportunity for first-principles simulation of a wide range of boiling and cavitating flows. The proposed algorithm enables unprecedented simulations of the Navier-Stokes-Korteweg equations involving cavitating flows at strongly under-critical conditions and $\mathcal{O}(10^5)$ Reynolds number. The proposed technique provides a pathway for fundamental understanding of phase-transforming flows with multiple applications in science, engineering, and medicine.

We present a Petrov-Gelerkin (PG) method for a class of nonlocal convection-dominated diffusion problems. There are two main ingredients in our approach. First, we define the norm on the test space as induced by the trial space norm, i.e., the optimal test norm, so that the inf-sup condition can be satisfied uniformly independent of the problem. We show the well-posedness of a class of nonlocal convection-dominated diffusion problems under the optimal test norm with general assumptions on the nonlocal diffusion and convection kernels. Second, following the framework of Cohen et al.~(2012), we embed the original nonlocal convection-dominated diffusion problem into a larger mixed problem so as to choose an enriched test space as a stabilization of the numerical algorithm. In the numerical experiments, we use an approximate optimal test norm which can be efficiently implemented in 1d, and study its performance against the energy norm on the test space. We conduct convergence studies for the nonlocal problem using uniform $h$- and $p$-refinements, and adaptive $h$-refinements on both smooth manufactured solutions and solutions with sharp gradient in a transition layer. In addition, we confirm that the PG method is asymptotically compatible.

Prostate cancer can be lethal in advanced stages, for which chemotherapy may become the only viable therapeutic option. While there is no clear clinical management strategy fitting all patients, cytotoxic chemotherapy with docetaxel is currently regarded as the gold standard. However, tumors may regain activity after treatment conclusion and become resistant to docetaxel. This situation calls for new delivery strategies and drug compounds enabling an improved therapeutic outcome. Combination of docetaxel with antiangiogenic therapy has been considered a promising strategy. Bevacizumab is the most common antiangiogenic drug, but clinical studies have not revealed a clear benefit from its combination with docetaxel. Here, we capitalize on our prior work on mathematical modeling of prostate cancer growth subjected to combined cytotoxic and antiangiogenic therapies, and propose an optimal control framework to robustly compute the drug-independent cytotoxic and antiangiogenic effects enabling an optimal therapeutic control of tumor dynamics. We describe the formulation of the optimal control problem, for which we prove the existence of at least a solution and determine the necessary first order optimality conditions. We then present numerical algorithms based on isogeometric analysis to run a preliminary simulation study over a single cycle of combined therapy. Our results suggest that only cytotoxic chemotherapy is required to optimize therapeutic performance and we show that our framework can produce superior solutions to combined therapy with docetaxel and bevacizumab. We also illustrate how the optimal drug-na\"{i}ve cytotoxic effects computed in these simulations may be successfully leveraged to guide drug production and delivery strategies by running a nonlinear least-square fit of protocols involving docetaxel and a new design drug.

We present the application of a class of deep learning, known as Physics Informed Neural Networks (PINN), to learning and discovery in solid mechanics. We explain how to incorporate the momentum balance and constitutive relations into PINN, and explore in detail the application to linear elasticity, and illustrate its extension to nonlinear problems through an example that showcases von~Mises elastoplasticity. While common PINN algorithms are based on training one deep neural network (DNN), we propose a multi-network model that results in more accurate representation of the field variables. To validate the model, we test the framework on synthetic data generated from analytical and numerical reference solutions. We study convergence of the PINN model, and show that Isogeometric Analysis (IGA) results in superior accuracy and convergence characteristics compared with classic low-order Finite Element Method (FEM). We also show the applicability of the framework for transfer learning, and find vastly accelerated convergence during network re-training. Finally, we find that honoring the physics leads to improved robustness: when trained only on a few parameters, we find that the PINN model can accurately predict the solution for a wide range of parameters new to the network---thus pointing to an important application of this framework to sensitivity analysis and surrogate modeling., Comment: 19 pages, 14 figures

We extend the recently introduced divergence-conforming immersed boundary (DCIB) method [1] to fluid-structure interaction (FSI) problems involving closed co-dimension one solids. We focus on capsules and vesicles, whose discretization is particularly challenging due to the higher-order derivatives that appear in their formulations. In two-dimensional settings, we employ cubic B-splines with periodic knot vectors to obtain discretizations of closed curves with C^2 inter-element continuity. In three-dimensional settings, we use analysis-suitable bi-cubic T-splines to obtain discretizations of closed surfaces with at least C^1 inter-element continuity. Large spurious changes of the fluid volume inside closed co-dimension one solids is a well-known issue for IB methods. The DCIB method results in volume changes orders of magnitude lower than conventional IB methods. This is a byproduct of discretizing the velocity-pressure pair with divergence-conforming B-splines, which lead to negligible incompressibility errors at the Eulerian level. The higher inter-element continuity of divergence-conforming B-splines is also crucial to avoid the quadrature/interpolation errors of IB methods becoming the dominant discretization error. Benchmark and application problems of vesicle and capsule dynamics are solved, including mesh-independence studies and comparisons with other numerical methods., Comment: For supplementary movies go to https://www.andrew.cmu.edu/user/hugocp/research.html

Cytotoxic chemotherapy is a common treatment for advanced prostate cancer. These tumors are also known to rely on angiogenesis, i.e., the growth of local microvasculature via chemical signaling produced by the tumor. Thus, several clinical studies have been investigating antiangiogenic therapy for advanced prostate cancer, either as monotherapy or combined with standard cytotoxic protocols. However, the complex genetic alterations promoting prostate cancer growth complicate the selection of the best chemotherapeutic approach for each patient's tumor. Here, we present a mathematical model of prostate cancer growth and chemotherapy that may enable physicians to test and design personalized chemotherapeutic protocols in silico. We use the phase-field method to describe tumor growth, which we assume to be driven by a generic nutrient following reaction-diffusion dynamics. Tumor proliferation and apoptosis (i.e., programmed cell death) can be parameterized with experimentally-determined values. Cytotoxic chemotherapy is included as a term downregulating tumor net proliferation, while antiangiogenic therapy is modeled as a reduction in intratumoral nutrient supply. Another equation couples the tumor phase field with the production of prostate-specific antigen, which is an extensively used prostate cancer biomarker. We prove the well-posedness of our model and we run a series of representative simulations using an isogeometric method to explore untreated tumor growth as well as the effects of cytotoxic chemotherapy and antiangiogenic therapy, both alone and combined. Our simulations show that our model captures the growth morphologies of prostate cancer as well as common outcomes of cytotoxic and antiangiogenic mono and combined therapy. Our model also reproduces the usual temporal trends in tumor volume and prostate-specific antigen evolution observed in previous studies.